Track the Zelluna ASA stock price and the full management transaction log of the company, a listed issuer based in Norway. Shares are quoted on NO NO, under the oversight of Oslo Børs. Operating in the Health Care sector, Zelluna ASA has recorded 30 public disclosures. The latest transaction was filed on 2 July 2026 (Option grant). Among the most active insiders: Chief Executive. The full history is free.
30
Insider Decl.
0
Thresholds
€591,870
21 ops.
Buy Volume
€1bn
3 ops.
Sell Volume
10Σ signal
Buys €591,870€1bn Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
500 shares@ NOK 79.003.2% of flowOptionXOSLOSLO:534102
Ideal exit: 19 Feb 2022 (T+270)
25 of 30 declarations
About Zelluna ASA
Zelluna ASA is a company focused on the health and pharmaceutical sector, specializing in the development of immunological therapies. It is listed on the XOSL market.